Hindocha Sumeet, Gopaluni Seerapani, Collins Graham P, Shenbagaraman Packiam
Oxford University Hospitals, Oxford, UK.
Royal Berkshire Hospital, Reading, UK.
BMJ Case Rep. 2015 Sep 9;2015:bcr2015211765. doi: 10.1136/bcr-2015-211765.
Mantle cell lymphoma (MCL) is a rare lymphoid neoplasm occurring in about 6% of all non-Hodgkin's lymphomas. Although nephrotic syndrome due to various glomerulopathies is well described in patients with lymphomas, focal segmental glomerulosclerosis (FSGS) with MCL has been reported only once before. We present a second case of FSGS associated with MCL that was resistant to standard treatment of FSGS but resolved when the underlying MCL was treated.
套细胞淋巴瘤(MCL)是一种罕见的淋巴样肿瘤,约占所有非霍奇金淋巴瘤的6%。尽管淋巴瘤患者中因各种肾小球病导致的肾病综合征已有详细描述,但MCL合并局灶节段性肾小球硬化(FSGS)此前仅报道过一例。我们报告了第二例与MCL相关的FSGS,该病例对FSGS的标准治疗耐药,但在潜在的MCL得到治疗后病情缓解。